These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32883331)

  • 1. Modeling tumor development and metastasis using paired organoids derived from patients with colorectal cancer liver metastases.
    Li H; Dai W; Xia X; Wang R; Zhao J; Han L; Mo S; Xiang W; Du L; Zhu G; Xie J; Yu J; Liu N; Huang M; Zhu J; Cai G
    J Hematol Oncol; 2020 Sep; 13(1):119. PubMed ID: 32883331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer.
    Li Y; Lv Z; He G; Wang J; Zhang X; Lu G; Ren X; Wang F; Zhu X; Ding Y; Liao W; Ding Y; Liang L
    Oncotarget; 2015 Apr; 6(11):9099-112. PubMed ID: 25868860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adaptation of colorectal cancer cells when forming metastases in the liver: expression of associated genes and pathways in a mouse model.
    Bocuk D; Wolff A; Krause P; Salinas G; Bleckmann A; Hackl C; Beissbarth T; Koenig S
    BMC Cancer; 2017 May; 17(1):342. PubMed ID: 28525976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer liver metastases organoids retain characteristics of original tumor and acquire chemotherapy resistance.
    Buzzelli JN; Ouaret D; Brown G; Allen PD; Muschel RJ
    Stem Cell Res; 2018 Mar; 27():109-120. PubMed ID: 29414601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Colorectal Cancer Progression Through Orthotopic Implantation of Organoids.
    de Sousa E Melo F; Harnoss JM; Kljavin N; Scott R; Sohn C; Leong KG; de Sauvage FJ
    Methods Mol Biol; 2020; 2171():331-346. PubMed ID: 32705654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer.
    Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J
    J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer.
    Boos SL; Loevenich LP; Vosberg S; Engleitner T; Öllinger R; Kumbrink J; Rokavec M; Michl M; Greif PA; Jung A; Hermeking H; Neumann J; Kirchner T; Rad R; Jung P
    Cell Mol Gastroenterol Hepatol; 2022; 13(2):517-540. PubMed ID: 34700030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling.
    Vishnoi M; Liu NH; Yin W; Boral D; Scamardo A; Hong D; Marchetti D
    Mol Oncol; 2019 Sep; 13(9):1913-1926. PubMed ID: 31216110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis of Patient-Matched PDOs Revealed a Reduction in OLFM4-Associated Clusters in Metastatic Lesions in Colorectal Cancer.
    Okamoto T; duVerle D; Yaginuma K; Natsume Y; Yamanaka H; Kusama D; Fukuda M; Yamamoto M; Perraudeau F; Srivastava U; Kashima Y; Suzuki A; Kuze Y; Takahashi Y; Ueno M; Sakai Y; Noda T; Tsuda K; Suzuki Y; Nagayama S; Yao R
    Stem Cell Reports; 2021 Apr; 16(4):954-967. PubMed ID: 33711267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
    Solano-Iturri JD; Beitia M; Errarte P; Calvete-Candenas J; Etxezarraga MC; Loizate A; Echevarria E; Badiola I; Larrinaga G
    Aging (Albany NY); 2020 May; 12(11):10337-10358. PubMed ID: 32428869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population.
    Kasashima H; Duran A; Martinez-Ordoñez A; Nakanishi Y; Kinoshita H; Linares JF; Reina-Campos M; Kudo Y; L'Hermitte A; Yashiro M; Ohira M; Bao F; Tauriello DVF; Batlle E; Diaz-Meco MT; Moscat J
    Dev Cell; 2021 Jan; 56(1):95-110.e10. PubMed ID: 33207226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.
    Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y
    Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases.
    Jian M; Ren L; He G; Lin Q; Tang W; Chen Y; Chen J; Liu T; Ji M; Wei Y; Chang W; Xu J
    J Transl Med; 2020 Jun; 18(1):234. PubMed ID: 32532289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global-scale profiling of differential expressed lysine acetylated proteins in colorectal cancer tumors and paired liver metastases.
    Shen Z; Wang B; Luo J; Jiang K; Zhang H; Mustonen H; Puolakkainen P; Zhu J; Ye Y; Wang S
    J Proteomics; 2016 Jun; 142():24-32. PubMed ID: 27178108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis.
    Zhou ZH; Song JW; Li W; Liu X; Cao L; Wan LM; Tan YX; Ji SP; Liang YM; Gong F
    J Exp Clin Cancer Res; 2017 Sep; 36(1):130. PubMed ID: 28927426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.
    Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK
    World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.